These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14521410)

  • 61. Aggregating behavior of phenolic compounds--a source of false bioassay results?
    Pohjala L; Tammela P
    Molecules; 2012 Sep; 17(9):10774-90. PubMed ID: 22960870
    [TBL] [Abstract][Full Text] [Related]  

  • 62. How Do Small Molecule Aggregates Inhibit Enzyme Activity? A Molecular Dynamics Study.
    Ghattas MA; Al Rawashdeh S; Atatreh N; Bryce RA
    J Chem Inf Model; 2020 Aug; 60(8):3901-3909. PubMed ID: 32628846
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Kinetics and mechanisms of peptide aggregation. I: Aggregation of a cholecystokinin analogue.
    Silvestri S; Lu MY; Johnson H
    J Pharm Sci; 1993 Jul; 82(7):689-93. PubMed ID: 8360841
    [TBL] [Abstract][Full Text] [Related]  

  • 64. SCAM Detective: Accurate Predictor of Small, Colloidally Aggregating Molecules.
    Alves VM; Capuzzi SJ; Braga RC; Korn D; Hochuli JE; Bowler KH; Yasgar A; Rai G; Simeonov A; Muratov EN; Zakharov AV; Tropsha A
    J Chem Inf Model; 2020 Aug; 60(8):4056-4063. PubMed ID: 32678597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Updated Prediction of Aggregators and Assay-Interfering Substructures in Food Compounds.
    Sánchez-Ruiz A; Colmenarejo G
    J Agric Food Chem; 2021 Dec; 69(50):15184-15194. PubMed ID: 34878782
    [TBL] [Abstract][Full Text] [Related]  

  • 66. How promiscuous are pharmaceutically relevant compounds? A data-driven assessment.
    Hu Y; Bajorath J
    AAPS J; 2013 Jan; 15(1):104-11. PubMed ID: 23090085
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Physicochemical characteristics of structurally determined metabolite-protein and drug-protein binding events with respect to binding specificity.
    Korkuć P; Walther D
    Front Mol Biosci; 2015; 2():51. PubMed ID: 26442281
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
    Tomohara K; Adachi I; Horino Y; Kesamaru H; Abe H; Suyama K; Nose T
    ACS Med Chem Lett; 2019 Jun; 10(6):923-928. PubMed ID: 31223449
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sessile animals: attached, but promiscuous?
    Bishop JD; Pemberton AJ
    Trends Ecol Evol; 1997 Oct; 12(10):403. PubMed ID: 21238130
    [No Abstract]   [Full Text] [Related]  

  • 70. Can children be promiscuous?
    Hanks A
    Can Fam Physician; 1983 May; 29():870. PubMed ID: 21283364
    [No Abstract]   [Full Text] [Related]  

  • 71. A Clinical Appraisal of Some Sexually Promiscuous Females.
    McBroom MS
    J Natl Med Assoc; 1963 Jul; 55(4):290-4. PubMed ID: 20894135
    [No Abstract]   [Full Text] [Related]  

  • 72. A detergent-based assay for the detection of promiscuous inhibitors.
    Feng BY; Shoichet BK
    Nat Protoc; 2006; 1(2):550-3. PubMed ID: 17191086
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An Aggregation Advisor for Ligand Discovery.
    Irwin JJ; Duan D; Torosyan H; Doak AK; Ziebart KT; Sterling T; Tumanian G; Shoichet BK
    J Med Chem; 2015 Sep; 58(17):7076-87. PubMed ID: 26295373
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High-throughput assays for promiscuous inhibitors.
    Feng BY; Shelat A; Doman TN; Guy RK; Shoichet BK
    Nat Chem Biol; 2005 Aug; 1(3):146-8. PubMed ID: 16408018
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A high-throughput screen for aggregation-based inhibition in a large compound library.
    Feng BY; Simeonov A; Jadhav A; Babaoglu K; Inglese J; Shoichet BK; Austin CP
    J Med Chem; 2007 May; 50(10):2385-90. PubMed ID: 17447748
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.
    Coan KE; Shoichet BK
    J Am Chem Soc; 2008 Jul; 130(29):9606-12. PubMed ID: 18588298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Screening in a spirit haunted world.
    Shoichet BK
    Drug Discov Today; 2006 Jul; 11(13-14):607-15. PubMed ID: 16793529
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tackling assay interference associated with small molecules.
    Tan L; Hirte S; Palmacci V; Stork C; Kirchmair J
    Nat Rev Chem; 2024 May; 8(5):319-339. PubMed ID: 38622244
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening Profiles.
    Thomas JR; Shelton C; Murphy J; Brittain S; Bray MA; Aspesi P; Concannon J; King FJ; Ihry RJ; Ho DJ; Henault M; Hadjikyriacou A; Neri M; Sigoillot FD; Pham HT; Shum M; Barys L; Jones MD; Martin EJ; Blechschmidt A; Rieffel S; Troxler TJ; Mapa FA; Jenkins JL; Jain RK; Kutchukian PS; Schirle M; Renner S
    ACS Chem Biol; 2024 Apr; 19(4):938-952. PubMed ID: 38565185
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular dynamics simulations as a guide for modulating small molecule aggregation.
    Nesabi A; Kalayan J; Al-Rawashdeh S; Ghattas MA; Bryce RA
    J Comput Aided Mol Des; 2024 Mar; 38(1):11. PubMed ID: 38470532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.